Why Your MCAS Gets Worse Before Your Period
MCAS Decoded · Hormones + Cycle
Estrogen, mast cells, and the cycle-symptom connection no one warned you about. If your flares follow a pattern, that pattern has a biological explanation — and it changes how you approach healing.
By Poppy · IWHI Certified Endometriosis + Women's Health Coach | MCAS Decoded | 10 min read
If you've noticed that your MCAS symptoms follow a monthly pattern — that the week before your period is your worst week, that ovulation brings a spike in reactivity, that you feel almost human in the follicular phase and like your body is actively betraying you in the luteal — you are not imagining it. You are observing a documented biological phenomenon that most healthcare providers are not connecting to MCAS, even when it's right in front of them.
The estrogen-mast cell relationship is one of the most clinically significant and least-discussed pieces of the MCAS puzzle. Understanding it doesn't just explain your pattern. It changes your entire approach to managing and healing the condition — because it means that addressing your hormonal environment is not optional. It is part of the treatment.
This is the post I needed when I was 36 years old, one year post-hysterectomy, on an estrogen patch dose I now believe was too low for my body's needs — watching my immune system come completely apart while my gynecologist focused on whether my menopause symptoms were "managed."
The Estrogen-Mast Cell Connection
Estrogen and mast cells have a relationship that runs in both directions — and both directions matter.
First: estrogen directly activates mast cells. It does this by increasing the number and sensitivity of IgE receptors on mast cell surfaces, lowering the threshold for degranulation, and upregulating the production of certain inflammatory mediators. Simply put: higher estrogen means more reactive mast cells, responding more readily to triggers that might otherwise stay below the threshold.
Second: mast cells produce estrogen. Mast cells contain aromatase — the enzyme that converts androgens to estrogen — and actively contribute to local estrogen production, particularly in tissues where they're densely concentrated, like the gut, the skin, and the endometrium. This is part of why endometriosis, which is fundamentally driven by estrogen, and MCAS are so deeply intertwined. The mast cells in endometriotic lesions are not passive bystanders. They are active participants in maintaining the hormonal environment that sustains the condition.
Third: mast cells are sensitive to estrogen fluctuations, not just elevated estrogen. The rapid shift in estrogen levels — particularly the drop that occurs in the late luteal phase, in the days just before menstruation — can trigger mast cell reactivity even when absolute estrogen levels aren't high. This is why some women with MCAS experience their worst symptoms not at peak estrogen (around ovulation) but in the late luteal phase, when estrogen is falling and the nervous system is also navigating the hormonal withdrawal of progesterone.
““Your flares are not random. They are your hormonal cycle, written in your immune system’s language.””
Your Cycle, Phase by Phase
If you still have your cycle — or if you're navigating HRT and trying to understand how your dosing affects your symptoms — understanding how MCAS activity typically tracks across the four phases gives you a framework for anticipating and supporting your body proactively.
Menstrual Phase (Days 1–5)
Estrogen and progesterone are at their lowest. For many women with MCAS, this is a high-symptom phase — the prostaglandins released during menstruation directly activate mast cells, and the hormonal floor can trigger reactivity. Cramps, nausea, digestive upset, and skin flares are common.
Follicular Phase (Days 6–13)
Rising estrogen begins to stabilize, and for many women this is the clearest, most tolerable phase. Food reactions may be milder. Energy is better. The nervous system often has more capacity. If you have a "good week," it's likely here.
Ovulation (Around Day 14)
The estrogen surge at ovulation can spike mast cell reactivity for some women — particularly those with estrogen dominance or high baseline reactivity. Mid-cycle headaches, skin flushing, and digestive symptoms are common during this window.
Luteal Phase (Days 15–28)
This is where most MCAS patients struggle most. Progesterone rises and then both hormones drop in the late luteal phase. Mast cell reactivity peaks. Histamine is less efficiently broken down. Nervous system tolerance is lower. Food triggers are more potent. If your body has a worst week, it's almost always here.
Practical Note
The best time to reintroduce eliminated foods is the follicular phase
If you're testing whether you can tolerate a previously reactive food, do it in days 6–12 of your cycle — when estrogen is rising but not yet peaked and your mast cell threshold is at its highest. Testing in the luteal phase will skew your results toward reactivity that may not be representative of your actual tolerance.
Endometriosis, MCAS, and the Cluster
If you have endometriosis and MCAS, you are not unlucky — you are experiencing what the research increasingly describes as a biological cluster. A 2025 UK Biobank study identified shared genetic architecture between endometriosis, MCAS, POTS, and hypermobile Ehlers-Danlos Syndrome. These conditions co-occur at rates far above chance.
The mechanisms connect at multiple points. Endometriotic lesions are densely infiltrated with mast cells. Those mast cells release mediators — including histamine, prostaglandins, and nerve growth factor — that directly drive the pain, inflammation, and progressive lesion growth of endometriosis. Meanwhile, the systemic inflammatory environment created by endometriosis keeps the immune system primed and mast cells on high alert throughout the body, not just locally.
Estrogen drives both. Mast cells amplify both. Nervous system dysregulation — which is nearly universal in women who have been in chronic pain for years — worsens both.
This is why treating endometriosis and MCAS as two completely separate conditions managed by two separate specialists, with no communication between them, produces such incomplete results. They share root drivers. They require an integrated approach.
Long COVID, Hormones, and the Unmasking Problem
For women whose MCAS emerged or dramatically worsened after COVID-19, the hormonal connection is still relevant. Emerging research suggests that COVID spike protein can directly bind to mast cell receptors and trigger degranulation — essentially acting as a potent mast cell activator in susceptible individuals. In women with pre-existing hormonal imbalances or subclinical mast cell susceptibility, COVID doesn't create MCAS so much as it unmasks it: pushes the already-sensitized system over a threshold that may have been approached for years.
If your MCAS appeared post-COVID and you also have hormonal dysregulation, addressing both simultaneously — rather than focusing on COVID recovery in isolation — is likely to produce better outcomes.
Post-Surgical Hormonal Shifts and MCAS
I want to speak directly to women who have had hysterectomies, oophorectomies, or other surgeries that affect hormonal output — because this is not discussed enough in MCAS spaces, and it is exactly what happened to me.
Surgical menopause — the abrupt loss of ovarian estrogen production following oophorectomy — creates an immediate, dramatic hormonal shift that can destabilize a previously managed or subclinical mast cell condition. Unlike natural menopause, which involves a gradual decline in estrogen over years, surgical menopause is immediate. The mast cells, accustomed to a certain hormonal environment, are suddenly operating in completely different conditions.
HRT following surgical menopause is not optional for most women — it's medically necessary for bone health, cardiovascular health, and cognitive function, as well as symptom management. But the dose and delivery method matter enormously for MCAS. Oral estrogen is metabolized through the gut and liver, producing higher peak estrogen levels and greater fluctuation — both of which can be problematic for mast cells. Transdermal delivery (patches, gels, creams) produces more stable estrogen levels with lower peak concentrations, and is generally better tolerated by women with mast cell conditions.
If your MCAS emerged or worsened after a hysterectomy or oophorectomy, the adequacy and delivery method of your HRT is worth a direct and detailed conversation with a provider who understands both hormonal and immune considerations. If your provider isn't connecting these dots — find one who will.
My experience: My hysterectomy was at 35. My MCAS symptoms peaked at 36–37. I believe my estrogen patch dose was too low for my body's needs — combined with extreme stress around my divorce, a history of histamine intolerance, and endometriosis, it created the perfect convergence of triggers. Getting my estrogen addressed was part of my path to remission. It wasn't the only part — but it wasn't separable from the rest of the work either.
What to Do With This Information
Start tracking your cycle alongside your symptoms if you aren't already. Even a basic notation of your cycle day each day in your flare tracker will reveal patterns within one to two cycles. Apps like Clue, Natural Cycles, or even a simple paper calendar work. You're looking for whether your worst symptom days cluster in the luteal phase, whether ovulation brings a reactivity spike, and whether you have a reliable "window" of lower reactivity in the follicular phase.
Once you can see the pattern, you can work with it. Planning higher-histamine meals, more intensive exercise, or food reintroductions for the follicular window. Supporting your body more aggressively — more rest, more nervous system practices, more somatic support — in the luteal phase, particularly in days 22–28. Talking to your provider about whether your hormonal environment is optimized, whether you're on HRT and whether the dose and delivery method are appropriate, and whether estrogen-related testing is warranted.
The cycle isn't working against you. It's giving you a map. The question is whether you're reading it.
Up Next
The 4-Layer MCAS Framework
Now that you understand what's driving MCAS and how hormones amplify it, the next post lays out the integrated healing framework — addressing gut, nervous system, hormones, and triggers together. Because knowing what's wrong is only the beginning. → Post 3: The 4-Layer MCAS Framework
Related Free Resource
If you have both endometriosis and MCAS, the Endo Warrior Kit was made for you
Covers the endo-MCAS-hormonal overlap, patient advocacy tools, and the integrated approach to managing both conditions.
